CALEX Cap Updates- Extended Stability, Training Video & CALEX Cap 4.0

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use.
BÜHLMANN fPELA® turbo is FDA 510(k) Exempt. For in vitro Diagnostic Use.
CPT Code: Pancreatic Elastase- 123234

CALEX® Cap Updates

CALEX Cap 4.0- Improved Total Laboratory Automation (TLA), or Block Automation & Seamless Integration

  • TLA Compatibility: CALEX®Cap 4.0 integrates smoothly with TLA, enhancing workflow efficiency on track systems.
  • Block Automation: no track, CALEX® Cap 4.0 integrates with decapping units to mitigate repetitive motion injuries and keep lab techs happy.
  • New LONGER EXTRACT Stability!
    • Special 510(k) clearance for CALEX® Cap (K232057) with fCAL® turbo, which extends the extraction stability to 2 days @ RT and 15 days @ 2-8°C.
  • Seamless Integration: CALEX® Cap 4.0 improves stool sample preparation without changing procedure (no re-validation required), meeting TLA requirements seamlessly.
    • Learn how CALEX® Cap Streamlines Workflow for Calprotectin testing with fCAL® turbo in this video- See it in action

Training Video

View tutorial for expert guidance!

  • Elevate Training Impact: See the key steps to enhance user proficiency, view simplicity of procedure, and maximize the benefits of CALEX® Cap.